Thomas Schlange
0000-0002-2027-3976
Publication & Citation Trends
Publications
0 total
Neutrophil elastase activity following cathepsin C (CatC, or DPP1) inhibition with BI 1291583 in people with bronchiectasis
Cited by 0
Semantic Scholar
A Small Molecule–Drug Conjugate (SMDC) Consisting of a Modified Camptothecin Payload Linked to an αVß3 Binder for the Treatment of Multiple Cancer Types OA
Cited by 15
Semantic Scholar
Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non–Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors OA
Cited by 42
Semantic Scholar
Abstract 1314: A novel small molecule drug conjugate -avb3 integrin antagonist linked to a cytotoxic camptothecin derivative- for the treatment of multiple cancer types
Cited by 0
Semantic Scholar
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID. OA
Cited by 32
Semantic Scholar
Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis OA
Cited by 18
Semantic Scholar
Integrating circulating miRNA analysis in the clinical management of lung cancer: Present or future? OA
Cited by 29
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(18)
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
(10)
Cancer Cells and Metastasis
(9)
Congenital heart defects research
(9)
Lung Cancer Treatments and Mutations
(6)
Affiliations
Novartis (Switzerland)
Boehringer Ingelheim (Germany)
University of Alabama at Birmingham
Bayer (Germany)
Friedrich Miescher Institute